Fund profile
Enso Ventures
United Kingdom
Leading
About
Enso Ventures is a private investment firm founded in 2010, with offices in London and New York. The firm focuses on selective equity investments in high-technology and biotechnology companies, particularly in Europe and the United States. Enso Ventures leverages its industry expertise and capital to accelerate the commercial development of startup companies in fields like materials technology and life sciences. Enso Ventures typically participates in Series A rounds and later, with an average round size of around $6 million. The firm has built a portfolio of 15 companies, with 7 successful exits to date. Notable investments include companies like Cavion, which focuses on innovative pharmaceutical solutions, NeuroVia, specializing in drug discovery, and Seres Therapeutics, a leader in biotechnology. Enso Ventures aims to back startups that are poised to drive significant advancements in their industries, with a focus on developing disruptive technologies in both the biotech and materials tech sectors.
Details
Highlights
$5.2M
Historical average check
$26.1M
Historical max check
October 2017
Last investment date
15
Investments
Biotech
Healthtech & Wellness
Pharma
Natural Resources
Software & Apps
Security & Privacy
Hardware. Robotics & IoT
Real Estate & Proptech
Media, Events & Entertainment
Showing 0 lists
Contacts
Website
ensoventures.comSocial
Lists that include this fund